Haleon plc

Healthcare

NYSE:HLN · New York Stock Exchange

Market Cap $40.33B Beta 0.25 P/E (TTM) 29.4

$9.14 +1.16%

+$0.11 today

52W Low $8.65High $11.28

Vol 5.95M · Avg 8.66M

EPS (TTM)$0.11

Div Yield2.11%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-15.38%

Period High

$11.12

Period Low

$8.61

Latest

$9.13

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Becton, Dickinson and Company

NYSE:BDX

$52.81B

Cardinal Health, Inc.

NYSE:CAH

$52.30B

Takeda Pharmaceutical Company Limited

NYSE:TAK

$50.48B

Humana Inc.

NYSE:HUM

$45.43B

Agilent Technologies, Inc.

NYSE:A

$36.56B

Zoetis Inc.

NYSE:ZTS

$33.66B

Alcon Inc.

NYSE:ALC

$32.51B

IQVIA Holdings Inc.

NYSE:IQV

$29.85B

ResMed Inc.

NYSE:RMD

$28.03B

Insmed Incorporated

NASDAQ:INSM

$21.22B

What is the latest HLN filing?

The latest filing shown is 6-K dated Jun 8, 2026.

How many recent filings does HLN have?

Intrinsic Alpha currently shows 20 recent filings for HLN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.